CSIMarket Company Name, Ticker, Competitors, else..
 

Cardiol Therapeutics inc   (NASDAQ: CRDL)

Cardiol Therapeutics Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

CRDL Sales vs. its Competitors Q4 2025


Comparing the current results to its competitors, Cardiol Therapeutics Inc reported Revenue decrease in the 4 quarter 2025 year on year by 0 %, despite the revenue increase by the most of its competitors of 10.32 %, recorded in the same quarter.

• List of CRDL Competitors





Revenue Growth Comparisons




Net Income Comparison

Cardiol Therapeutics inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 16.14 %

<<  CRDL Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Cardiol Therapeutics inc




Scholar Rock Holding Corp
Share Performance



-5.07%
30 Days
Scholar Rock Holding Corp
Profile

Scholar Rock Holding Corp operates using a business model focused on the development of innovative therapies for the treatment of diseases.

More about Scholar Rock Holding Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6,453.575 mill. $ - mill. $ -408.591 mill.


Scinai Immunotherapeutics Ltd
Share Performance



+568.86%
30 Days
Scinai Immunotherapeutics Ltd
Profile

The company develops therapeutics and operates as a contract development and manufacturing organization (CDMO).

More about Scinai Immunotherapeutics Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 1.311 mill. $ -8.307 mill.


Sab Biotherapeutics Inc
Share Performance



-8.09%
This Year
Sab Biotherapeutics Inc
Profile

Sab Biotherapeutics Inc's business model focuses on developing and producing innovative antibody therapeutics using advanced genetic engineering techniques.

More about Sab Biotherapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 276.344 mill. $ - mill. $ -12.775 mill.


Recursion Pharmaceuticals Inc
Share Performance



+4.92%
This Quarter
Recursion Pharmaceuticals Inc
Profile

Recursion Pharmaceuticals Inc is a biotech company that utilizes its artificial intelligence (AI) platform to identify and develop potential drug candidates. They employ a unique approach by combining AI technology with experimental biology and automation to accelerate drug discovery. Recursion applies its platform to identify new treatments for rare diseases and have established partnerships with various organizations in the pharmaceutical industry.

More about Recursion Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,759.781 mill. $ 54.855 mill. $ -518.884 mill.


Quince Therapeutics Inc
Share Performance



-19.20%
30 Days
Quince Therapeutics Inc
Profile

The company files an annual report that includes financial and operational disclosures.

More about Quince Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 169.083 mill. $ - mill. $ 78.293 mill.

54 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Cardiol Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cardiol Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.